Synapse - Steven Horwitz

Results (664)

Cutaneous ATLL is a diagnostic challenge and has heterogenous clinical and histologic features

Meeting Abstract

Marchetti, M. A.; Pulitzer, M.; Myskowski, P.; Dusza, S.; Lunning, M.; Horwitz, S.; Moskowitz, A.; Querfeld, C.
Journal of Investigative Dermatology (2014)

Fulltext@MSK | Save

How I treat the peripheral T-cell lymphomas

Journal Article

Moskowitz, A. J.; Lunning, M. A.; Horwitz, S. M.
Blood (2014)

Fulltext@MSK | Save

Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face

Journal Article

Li, J. Y.; Guitart, J.; Pulitzer, M. P.; Subtil, A.; Sundram, U.; Kim, Y.; Deonizio, J.; Myskowski, P. L.; Moskowitz, A.; Horwitz, S.; more...
American Journal of Dermatopathology (2014)

Fulltext@MSK | Save

Final results of phase II trial of doxorubicin HCI liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma

Journal Article

Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P. L.
Annals of Oncology (2014)

Fulltext@MSK | Save

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part II. Prognosis, management, and future directions

Journal Article

Jawed, S. I.; Myskowski, P. L.; Horwitz, S.; Moskowitz, A.; Querfeld, C.
Journal of the American Academy of Dermatology (2014)

Fulltext@MSK | Save

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers

Journal Article

Jawed, S. I.; Myskowski, P. L.; Horwitz, S.; Moskowitz, A.; Querfeld, C.
Journal of the American Academy of Dermatology (2014)

Fulltext@MSK | Save

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: Pivotal study update demonstrates durable responses

Journal Article

Coiffier, B.; Pro, B.; Prince, H. M.; Foss, F.; Sokol, L.; Greenwood, M.; Caballero, D.; Morschhauser, F.; Wilhelm, M.; Pinter-Brown, L.; more...
Journal of Hematology & Oncology (2014)

Fulltext@MSK | Save

Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with relapsed/refractory CLL

Meeting Abstract

Patel, M. R.; Kahl, B. S.; Horwitz, S. M.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Faia, K.; Kelly, P. F.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial